Completed NA INTERVENTIONAL NCT00276029

TNF Alpha in Refractory Asthma

The Efficacy of a Soluble Ligand Binding Tumour Necrosis Factor Receptor, Etanercept, in Severe, Steroid Dependant Asthma: a Randomised Controlled Study

Sponsor: University Hospitals, Leicester

Conditions Asthma

Interventions Etanercept

Updated 5 times since 2017 Last updated: May 3, 2006 Started: Dec 31, 2003 Completion: Sep 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00276029, this NA trial focuses on Asthma and remains completed. Sponsored by University Hospitals, Leicester, it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospitals, Leicester

Data source: University Hospitals, Leicester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leicester, United Kingdom